About Scientech Medical
Scientech Medical is a publicly listed company based in Shanghai (China) founded in 2021. It operates as a medical devices for cardiovascular diseases are developed. The company has 314 employees. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its competitors include Orchestra BioMed, Biotronik, Inquis Medical, Spectrumedics and Synaptic Medical and 4 more; 7 of its 9 listed competitors have raised funding.
Company details
The company was founded in 2021 and is based in Shanghai, China. Focus is placed on developing medical devices within the cardiovascular sector, targeting interventional treatments for congenital heart disease, stroke, valvular diseases, and related conditions. Products encompass series for left atrial appendage occlusion and patent foramen ovale closure to address cardiogenic stroke prevention and treatment, alongside biological intervention valves for valvular stenosis and insufficiency.
- Headquarters Shanghai, China
- Employees 314
- Stage Public
- SectorsHealthcare
- Phone•••• ••••
- Website scientechmed.com
- Legal Name Lepu Scientech Medical Technology (Shanghai) Co., Ltd. Class H
- Annual Revenue$73.56 M (USD)11.97as on Dec 31, 2025
- Net Profit$33.4 M (USD)-2.35as on Dec 31, 2025
- EBITDA$38.26 M (USD)2.5as on Dec 31, 2025
- Employee Count314
IPO & Listings of Scientech Medical
Scientech Medical is a publicly listed company on the HKEX with ticker symbol 2291 in Hong Kong, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date08 Nov 2022
- Listed onHKG: 2291
- Listed entityLEPU ScienTech Medical Technology (Shanghai) Co., Ltd. Class H
- Exchange sectorCommercial services
- ISINCNE1000057M5
- Share price13.17 HKD (-2.44% on the day) · 2026-10-14
- Market capitalisation4,628,812,500.00 HKD
- Price to earnings19.8
- EPS (diluted, trailing year)0.67 HKD
- Dividend yield4.24%
- Volume (last session)189,000
Financials of Scientech Medical
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 572.6M HKD | 260.0M HKD | 297.9M HKD |
| 2024 | 511.4M HKD | 266.2M HKD | 290.6M HKD |
| 2023 | 360.9M HKD | 167.3M HKD | 172.7M HKD |
| 2022 | 288.0M HKD | -23.0M HKD | 118.6M HKD |
| 2021 | 268.3M HKD | 70.7M HKD | 75.3M HKD |
Detailed financial statements for Scientech Medical
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Scientech Medical
Scientech Medical has 9 listed competitors in our database, 7 of them funded. They include Orchestra BioMed, Biotronik, Inquis Medical, Spectrumedics and Synaptic Medical, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| orchestrabiomed.com | 2017 | New Hope, United States | $205.88M | – | Medical devices for hypertension and atherosclerosis treatment are developed. | |
| biotronik.com | 1963 | Berlin, Germany | – | 1,196 | Cardiovascular products and equipment are developed, manufactured, and distributed. | |
| inquismedical.com | 2019 | Redwood, United States | $40M | – | Developer of medical device for the treatment of peripheral thrombectomy | |
| spectrumedics.com | 2018 | Singapore | $14.99M | – | Manufacturer of a therapeutic device for the treatment of arterial vascular calcification | |
| synapticmed.com | 2005 | Lake Forest, United States | $60M | – | Medical devices for cardiac arrhythmias and cardiovascular diseases are developed. | |
| cbmed.cn | 2018 | Shenzhen, China | $14.04M | – | Extracorporeal circulation products including ECMO are developed for medical support. | |
| techbankcapital.com | 2015 | Shanghai, China | $14.93M | – | Medical devices for cardiac disease treatment are developed. | |
| med-zenith.com | 2005 | Beijing, China | – | – | Electrosurgical devices for cardiovascular treatments are manufactured. | |
| pulsemed.cn | 2012 | Zhuhai, China | $1.45M | – | Cardiovascular medical devices are developed and manufactured in China. |
Detailed competitors of Scientech Medical
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Cardiac and Vascular Disorders
10 companies that operate in the same segment as Scientech Medical (Cardiac and Vascular Disorders), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Connected devices for health, sleep, and activity monitoring are developed. | 2008 | Moulineaux, Seine-maritime, France | USD 93.83 M | – | – | |
SMT is recognized as a developer of cardiovascular medical devices. | 1998 | Surat, Gujarat, India | – | USD 106.25 M | 1,090 | |
Gene-editing therapies for coronary artery disease are developed. | 2018 | Cambridge, Massachusetts, United States | USD 215.5 M | – | 255 | |
Cardiac monitoring devices and applications are provided for heart health. | 2010 | Mountain View, California, United States | USD 114.38 M | USD 6.18 M | 67 | |
Therapies for lowering low-density lipoprotein cholesterol levels are developed. | 1998 | Ann Arbor, Michigan, United States | USD 129.7 M | USD 332.31 M | 304 | |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided. | 2006 | San Francisco, California, United States | USD 109.23 M | USD 747.14 M | 2,000 | |
Provider of neuroprotection devices for carotid artery disease | 2007 | Sunnyvale, California, United States | USD 241.8 M | – | – | |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring. | 2007 | East Peoria, Illinois, United States | USD 154.77 M | – | 104 | |
Access catheters for neurovascular stroke treatment are provided. | 2015 | Campbell, California, United States | USD 596 M | – | – | |
Biosensor patches are developed for monitoring multiple body vitals. | 2011 | Campbell, California, United States | USD 239.95 M | – | 184 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Scientech Medical
Complete news archive for Scientech Medical
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Scientech Medical
Scientech Medical was founded in 2021.
Scientech Medical is headquartered in Shanghai, China.
Scientech Medical has 314 employees.
Annual revenue of Scientech Medical is $73.56M as on Dec 31, 2025.
The company was founded in 2021 and is based in Shanghai, China. Focus is placed on developing medical devices within the cardiovascular sector, targeting interventional treatments for congenital heart disease, stroke, valvular diseases, and related conditions. Products encompass series for left atrial appendage occlusion and patent foramen ovale closure to address cardiogenic stroke prevention and treatment, alongside biological intervention valves for valvular stenosis and insufficiency.
Scientech Medical's top competitors include Orchestra BioMed, Biotronik and Inquis Medical.
Yes, Scientech Medical is publicly traded on HKEX under the ticker symbol 2291.